From New Jersey EDA:
Join us for this panel session on Thursday, October 24 as biotech insiders share their insights on early stage life sciences investing.
About this Event
There is no cost to attend, but registration is requested prior to the event.
Hosted in partnership with:
Among the topics to be discussed:
How do angels and VCs evaluate and fund biotech entrepreneurs?
How do entrepreneurs secure funding?
Where do funding groups get their money, and how can an interested individual get involved in potential returns?
Peter Alff | Executive in Residence, Kairos Ventures
In his role as Executive in Residence at Kairos Ventures Peter works directly with founding scientists and their teams to develop and execute both scientific de-risking and commercialization strategies for Kairos portfolio companies. Peter provides management and business development guidance, enabling these companies to readily define and negotiate potential risks while maximizing progress towards key scientific and commercial milestones.
Tom Brennan | Venture Partner, ARCH Venture Partners
Tom Brennan joined ARCH in 2008 as a Venture Partner. He has special focus on ARCH activities at Sandia National Laboratories and Los Alamos National Laboratory, and the Life Sciences Accelerator in New York. During his first year with ARCH, he served as an Entrepreneur in Residence at Sandia National Laboratories (SNL), a position supported by a Department of Energy grant awarded to ARCH early in 2008.
James M. Golubieski | President, Foundation Venture Capital Group and New Jersey Health Foundation
James M. Golubieski is president of Foundation Venture Capital Group and New Jersey Health Foundation. Mr. Golubieski is a member of the New Jersey Economic Development Authority's Technology Advisory Board, which evaluates and recommends start-up companies for investment and the New Jersey Department of Labor and Workforce Development's BIO-1 Project, a plan to retain and expand high-quality jobs in central New Jersey's bioscience sector.
Tony Dimun | Medtech Angel Investor
Mr. Dimun is a serial entrepreneur with more than 30 years of successful operational, business development, and financial experience in the healthcare marketplace. During the last 20 years, Mr. Dimun has been a founder, investor, director, and mentor to over 21 emerging growth medical enterprises that have matured to commercial status. Of these enterprises, four became public companies and eleven were acquired.
Dr. Carolyn Myers | Principal, BioEnsemble LLC
Carolyn is a pharmaceutical executive with extensive experience optimizing productivity, creating value and increasing profitability with broad general management, business development and business strategy expertise in US and global markets. Adept at developing strategic plans and translating them into actionable objectives that drive performance and growth.
John Pennett | Partner, EisnerAmper LLC
John Pennett is the Partner-in-Charge of the Life Sciences Group and Technology Group at EisnerAmper. He has 30 years of public accounting experience, with a strong emphasis on public and private life science and technology companies. John is a frequent writer and speaker on topics related to issues impacting businesses in the life sciences and technology space. He is the publisher of Catalyst, a magazine focused solely on issues related to life sciences and pharmaceutical companies. John supports entrepreneurial organizations around the country with content and program development, and serves as a mentor to several early-stage companies.
The "Early Stage Investing in the Life Sciences" panel session will be hosted in the conference room of the New Jersey Bioscience Center - Incubator at North Brunswick, located at 675 US Highway One, North Brunswick, NJ 08902.
The Incubator at North Brunswick is the leading incubator in the region dedicated to life sciences and biotechnology companies. Labs range from approximately 900 – 1,300 sq. ft. and are “plug and play” ready. Tenant companies have shared access to conference rooms, reception services, two kitchens, loading docks, an NMR, dishwashing and autoclave. Separate private offices are also available.
The Incubator is located in the heart of New Jersey’s “Research Corridor” on the campus of The New Jersey Bioscience Center, a 50-acre research park which offers easy access to both New York City and Philadelphia, as well as close proximity to near Rutgers New Jersey Medical School and Princeton University. The New Jersey Bioscience Center itself is home to a number of successful biotech businesses including Chromocell, Allergan, Merial and Orthobond.For more information on the Incubator at North Brunswick, please contact Program Manager Lenzie Harcum at 732-839-1880 or firstname.lastname@example.org.